CFMS News and Press, Conformis Inc. From 03/02/22

Orthopedic devices company Conformis (CFMS +0.9%) said it is suspending deliveries of its products as well as business development in Russia. The company recently entered into a distribution agreement for its devices in the country. "While we were looking forward to working with our agents an...

BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its orthopedic medical devices. Additionally, until further notice, the company will no lon...

ConforMIS (NASDAQ:CFMS) is scheduled to announce Q4 earnings results on Wednesday, March 2nd, after market close. The consensus EPS Estimate is -$0.07 (+12.5% Y/Y) and the consensus Revenue Estimate is $15.61M (-6.5% Y/Y). For further details see: ConforMIS Q4 2021 Earnings Preview

BILLERICA, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), the pioneer and leader of fully personalized orthopedic medical devices, today announced results of a published retrospective study of patients showing the superiority of Conformis’ implants ...

BILLERICA, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced that the Orthopaedic Data Evaluation Panel in the United Kingdom ( ODEP ) awarded the Con...

3 Penny Stocks That Are Popular With Investors Right Now If you’re looking for popular penny stocks to add to your watchlist, there are hundreds to choose from. While it can be difficult to pick the best penny stocks for your watchlist, doing so can mean the difference betwee...

BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021, after the market closes ...

Company Launches Innovative Image-to-Implant ® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee ...

BILLERICA, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will provide a business update and initial expectations for 2022 before the market opens on Thursday, January 6, 2022, at approximately 7:00 a.m. Eastern Time. Mark Augusti, CEO,...

BILLERICA, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Brent Alldredge, Chief Legal Officer and Corporate Secretary, has notified the Company that he will be departing the Company on January 16, 2022 to become the General Counsel at Bruke...